|
Roche
F. Hoffmann-La Roche AG, commonly known as Roche (), is a Switzerland, Swiss multinational corporation, multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has Share (finance), shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceutical Co., Chugai Pharmaceuticals, as well as the United States–based companies Ventana Medical Systems, Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri fam ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Thomas Schinecker
Thomas Schinecker (born April 23, 1975 in Simbach am Inn) is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group. Early life Schinecker was born to an Austrian father and German mother in Simbach am Inn, West Germany. From the age of nine, he grew up in Singapore as the son of an ABB employee, and attended the German school. At the age of 19, he began studying genetics at the University of Salzburg, graduating with a bachelor's degree in 1997. He then continued his studies as a molecular biologist at New York University where he received his M.S in 2000 and Ph.D. in 2003. Career In 2003, Schinecker joined the Roche Group as a management trainee working in the Roche diagnostics division in several countries. In 2005, he transitioned to the diagnostics field and assumed the position of Head of Marketing and Sales ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Severin Schwan
Severin Anton Schwan (born 17 November 1967) is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group. Schwan joined the Roche Group in 1993 as a trainee and has stayed with the company ever since. Early life and education Severin Schwan graduated from the Akademisches Gymnasium Innsbruck and then studied economics at the University of Innsbruck, University of York, and University of Oxford as well as law at the University of Innsbruck. He completed both subjects in 1991 with a master's degree and acquired the title Mag. iur. and Mag. rer. soc. oec. He then obtained his Doctorate in Law in 1993. Career Schwan started his career as a trainee at the Roche office in Basel, Switzerland. He has worked in a number of positions across the globe for Roche. He was appointed CEO of the Roche Group at its Annual General Meeting on 4 March 2008, replacing Franz B. Humor. Previously, Schwan was managing director of Roc ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Roche Tower 2
Roche Tower 2 () is an office skyscraper in Basel, Switzerland. With a height of , the building replaced Roche Tower 1 as the tallest building in Switzerland after it opened on 2 September 2022. The building was financed by pharmaceutical company Hoffmann-La Roche and designed by Herzog & de Meuron. It accommodates 1,700 employees. The skyscraper is resistant towards earthquakes with a magnitude of 6.9 on the moment magnitude scale The moment magnitude scale (MMS; denoted explicitly with or Mwg, and generally implied with use of a single M for magnitude) is a measure of an earthquake's magnitude ("size" or strength) based on its seismic moment. was defined in a 1979 paper .... Gallery RocheArealBasel_01-20.jpg, Construction site in January 2020 RocheArealBasel_06-20.jpg, Construction site in June 2020 RocheBau2Basel_10-20.jpg, Construction site in October 2020 RocheBau2Basel_04-21.jpg, Construction site in April 2021 References External links Roche Tower 2at ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Genentech
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company. As of July 2021, Genentech employed 13,539 people. History The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer. Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of interest from one source, to be ligated into a similarly cut plasmid vector. While Cohen returned to the laboratory in academia, Swanson contacted Boyer to found the company. Boyer worked with Arthur Riggs (geneticist), Arthur Riggs and Keiichi Itakura from the Be ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche, later Fritz Hoffmann-von der Mühll (24 October 1868 18 April 1920), was a Swiss businessman who founded the pharmaceutical company F. Hoffmann-LaRoche & Co. Early life Fritz Hoffmann was born in Basel, Switzerland on 24 October 1868, the third child of Friedrich Hoffmann and Anna Elisabeth Merian. His godparents were his maternal grandfather Johan Heinrich Merian von der Mühll; his uncle, the Mayor of Basel, Carl Felix Burckhardt von der Mühll; and Anna Von der Mühll. His family were wealthy businesspeople from Basel's social elite (" the ''Daig''"). They provided both employment experience and investment at the beginning of his business career. In the 1870s and 80s, Hoffman completed primary and high school in Basel and advanced to complete an apprenticeship at a bank in the francophone part of Switzerland. When he returned to Basel in 1889, he entered a second internship at a pharmaceutical company.Wanner, Gustaf Adolf (1968). pp.25–27 Be ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Roche Tower
Roche Tower () is an Office building, office skyscraper in the Switzerland, Swiss city of Basel. At , it is the second List of tallest buildings in Switzerland, tallest building in the country. The building, also known as "Building 1" (), was financed by pharmaceutical company Hoffmann-La Roche and designed by Herzog & de Meuron. It cost 550 million Swiss francs to build. The entire construction ensemble, including the Roche Tower 2, "Building 2" research facility completed in 2022, was expected to cost three billion francs in total. When finished on 18 September 2015, Roche Tower overtook Prime Tower in Zürich as Switzerland's tallest building, the latter having held the record for four years. Strict planning laws mean there are few skyscrapers in the country. For the construction of the building, Earthquake-resistant structures, measures against earthquakes were envisioned and it stands on 143 pillars of reinforced concrete. It is supposed to endure an earthquake of 6.9 on th ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Basel
Basel ( ; ), also known as Basle ( ), ; ; ; . is a city in northwestern Switzerland on the river Rhine (at the transition from the High Rhine, High to the Upper Rhine). Basel is Switzerland's List of cities in Switzerland, third-most-populous city (after Zurich and Geneva), with 177,595 inhabitants within the city municipality limits. The official language of Basel is Swiss Standard German and the main spoken language is the local Basel German dialect. Basel is commonly considered to be the cultural capital of Switzerland and the city is famous for its many Museums in Basel, museums, including the Kunstmuseum Basel, Kunstmuseum, which is the first collection of art accessible to the public in the world (1661) and the largest museum of Swiss art, art in Switzerland, the Fondation Beyeler (located in Riehen), the Museum Tinguely and the Museum of Contemporary Art (Basel), Museum of Contemporary Art, which is the first public museum of contemporary art in Europe. Forty museums ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Ventana Medical Systems
Ventana Medical Systems, Inc. was a medical device company that develops, manufactures, and markets instrument reagent systems that automate tissue and slide staining in anatomic pathology laboratories. These products assist in the diagnosis and treatment of cancer and infectious diseases. The company is now part of the Roche Diagnostics Division and has been renamed Roche Tissue Diagnostics. History Pathologist and University of Arizona professor Thomas Grogan, M.D., founded Ventana in 1985. The company launched its first instrument reagent system in 1991, and held an initial public offering (IPO) in 1996, trading under the symbol VMSI on the NASDAQ stock exchange. In 2007, Ventana acquired Spring BioScience Corp, a developer and supplier of monoclonal antibodies. That same year, Ventana rejected a hostile takeover bid from Roche Holding AG for $75 a share.Doherty, Dermot (January 22, 2008)Roche’s Higher Offer Wins Ventana After Seven Months (Update11) Bloomberg. Retrieved N ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
André Hoffmann (businessman)
André Hoffmann (born 31 May 1958) is a Swiss billionaire businessman, environmentalist and philanthropist. The great-grandson of Fritz Hoffmann-La Roche who founded the drug company Roche Holding in 1896, he currently is the vice-chairman of the company. As of November 2020, his estimated net worth is US$5.71 billion As a philanthropist, he has been an advocate for sustainability and environmental protection, serving as International Vice-president of the World Wide Fund for Nature (WWF) from 2007 to 2017. He has also been on the boards oWetlands International the global non-profit organisation dedicated to the conservation and restoration of wetland ecosystems. Early life Born on 31 May 1958 in Basel, Switzerland, André Hoffmann is the son of Daria Hoffmann-Razumovsky and Luc Hoffmann, a conservationist and philanthropist. He studied economics at the University of St. Gallen, and holds an MBA from INSEAD, completed in 1990. Career In 1991, Hoffmann joined Nestlé UK ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas. History Foundation Medicine was founded in Cambridge, Massachusetts. The company was conceived after Broad Institute researchers Levi Garraway and Matthew Meyerson published a 2007 paper detailing a method for large-panel testing of 238 DNA mutations. Foundation Medicine launched in 2010 with a $25 million Series A financing led by Third Rock Ventures. The company released its first commercial assay, or test, called FoundationOne in 2012. The company also began partnering with pharmaceutical companies to analyze patient samples. The first such program was piloted with Novartis in 2011, and by 2018, the company had more than 30 partnerships. Foundation Medicine launched its second test, a hematological biomarker assay call ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Novartis
Novartis AG is a Swiss multinational corporation, multinational pharmaceutical company, pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; produced by Sandoz since 2023), terbinafine (Lamisil), deferasirox (Exjade), and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, ''novae artes'' (new skills). After the merger, other Ciba-Geigy and ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Chugai Pharmaceutical Co
is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. History Timeline This is a timeline of important events of Chugai Pharmaceutical. * 1925: Juzo Ueno founded Chugai Shinyaku Co. Ltd. and started importing and selling medicines * 1927: Start of the first own production * 1930: Salobrocanon, an analgesic (pain reliever ) and antipyretic, is launched * 1937: Calcium bromide production begins * 1943: Name changed to Chugai Pharmaceutical Co., Ltd. based in Tokyo * 1944: Acquisition of Matsunaga Pharmaceutical Ltd. and construction of a plant in Matsunaga * 1945: The headquarters, the factories in Ikebukuro, Sakai and Takada were destroyed in World War II, the headquarters were relocated to Takada, the factor ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
